Lurasidone set to transform Dainippon Sumitomo over the mid term
16 February 2010
Ian Haydock
Please Login to read the full article.
16 February 2010
Ian Haydock
ian.haydock@informa.com
Japan's Dainippon Sumitomo Pharma (DSP) has set out a new mid-term business plan under which it is aiming to raise group sales to ¥440.0 billion ($4.88 billion) over the next five years.
The figure is an increase of 49% from the forecast of ¥295.0 billion (excluding Sepracor) for...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
